Evidence-generation program

An evidence-generation program is a coordinated plan for producing clinical, real-world, and economic data to support the value and positioning of a pharmaceutical product.
https://www.visfo.health/glossary/evidence-generation-program

What is an evidence-generation program?

An evidence-generation program is a strategic framework used to plan, develop, and deliver data that demonstrates the clinical effectiveness, safety, economic value, and real-world impact of a pharmaceutical product. It includes both pre- and post-launch activities and may involve clinical trials, real-world evidence (RWE) studies, observational research, health economics and outcomes research (HEOR), and patient-reported outcomes (PROs). Programs are typically tailored to the needs of key stakeholders such as regulators, payers, providers, and patients.

Why are evidence-generation programs important?

Evidence-generation programs enable pharmaceutical companies to build a comprehensive value story, address stakeholder evidence requirements, and support market access and reimbursement. By generating relevant and credible data throughout the product lifecycle, companies can inform clinical decision-making, enhance competitive positioning, and meet evolving expectations for transparency, patient-centered outcomes, and long-term impact.

HelixAI
Analyze your landscape in seconds with an AI-enhanced knowledge management...
Discover HelixAI
VISFO
Consulting
Optimize your strategic decision-making
Collaborate seamlessly, solve key challenges with proven strategic frameworks, and unlock deeper insights through precision intelligence.
Discover Consulting